Icaritin promotes tumor T-cell infiltration and induces antitumor immunity in mice
- PMID: 31465113
- DOI: 10.1002/eji.201948225
Icaritin promotes tumor T-cell infiltration and induces antitumor immunity in mice
Abstract
Icaritin, a hydrolytic product of icariin isolated from traditional Chinese herbal medicine genus Epimedium, has many pharmacological and biological activities. Here, we show that icaritin can effectively decrease tumor burden of murine B16F10 melanoma and MC38 colorectal tumors in a T-cell dependent manner. The treatment effects are associated with increased CD8 T-cell infiltration and increased effector memory T-cell frequency. In vivo depletion of CD8 T cell using an anti-CD8 monoclonal antibody abolished the antitumor effect, which supports the critical role of CD8 T cells during icaritin treatment. By analyzing immune cells in the tumor tissue, we found reduced frequency of CD11b+ Gr1+ myeloid-derived suppression cells (MDSCs) infiltration and downregulation of PD-L1 expression on MDSCs after icaritin treatment. This was not limited to MDSCs, as icaritin also decreased the expression of PD-L1 on neutrophils. Importantly, the combination of anti-PD-1/CTLA-4 and icaritin significantly enhances antitumor ability and increases the efficacy of either treatment alone. Our findings reveal that icaritin induces antitumor immunity in a CD8 T-cell-dependent way and justify further investigation of combining immune checkpoint therapy to icaritin-based antitumor therapy.
Keywords: CD8 T-cells accumulation; Combination immunotherapy; Icaritin; MDSCs; Melanoma.
© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Similar articles
-
Icaritin Induces Anti-tumor Immune Responses in Hepatocellular Carcinoma by Inhibiting Splenic Myeloid-Derived Suppressor Cell Generation.Front Immunol. 2021 Feb 26;12:609295. doi: 10.3389/fimmu.2021.609295. eCollection 2021. Front Immunol. 2021. PMID: 33717093 Free PMC article.
-
Icaritin and intratumoral injection of CpG treatment synergistically promote T cell infiltration and antitumor immune response in mice.Int Immunopharmacol. 2022 Oct;111:109093. doi: 10.1016/j.intimp.2022.109093. Epub 2022 Aug 2. Int Immunopharmacol. 2022. PMID: 35930912
-
The helminth-derived peptide GK-1 induces an anti-tumoral CD8 T cell response associated with downregulation of the PD-1/PD-L1 pathway.Clin Immunol. 2020 Mar;212:108240. doi: 10.1016/j.clim.2019.07.006. Epub 2019 Jul 9. Clin Immunol. 2020. PMID: 31299381
-
Antitumor effects of icaritin and the molecular mechanisms.Discov Med. 2020 Jan-Feb;29(156):5-16. Discov Med. 2020. PMID: 32598859 Review.
-
New insights into the anticancer therapeutic potential of icaritin and its synthetic derivatives.Drug Dev Res. 2024 Apr;85(2):e22175. doi: 10.1002/ddr.22175. Drug Dev Res. 2024. PMID: 38567708 Review.
Cited by
-
Icaritin-induced immunomodulatory efficacy in advanced hepatitis B virus-related hepatocellular carcinoma: Immunodynamic biomarkers and overall survival.Cancer Sci. 2020 Nov;111(11):4218-4231. doi: 10.1111/cas.14641. Epub 2020 Sep 24. Cancer Sci. 2020. PMID: 32889778 Free PMC article.
-
A combination of PD‑1/PD‑L1 inhibitors: The prospect of overcoming the weakness of tumor immunotherapy (Review).Mol Med Rep. 2021 May;23(5):362. doi: 10.3892/mmr.2021.12001. Epub 2021 Mar 24. Mol Med Rep. 2021. PMID: 33760188 Free PMC article. Review.
-
Potential of Compounds Originating from the Nature to Act in Hepatocellular Carcinoma Therapy by Targeting the Tumor Immunosuppressive Microenvironment: A Review.Molecules. 2022 Dec 26;28(1):195. doi: 10.3390/molecules28010195. Molecules. 2022. PMID: 36615387 Free PMC article. Review.
-
Identification of a novel combination treatment strategy in clear cell renal cell carcinoma stem cells with shikonin and ipilimumab.Front Immunol. 2023 Aug 9;14:1186388. doi: 10.3389/fimmu.2023.1186388. eCollection 2023. Front Immunol. 2023. PMID: 37622107 Free PMC article.
-
Analysis of Clinical Trials of New Drugs for Liver Diseases in China.Drug Des Devel Ther. 2021 Jul 20;15:3181-3191. doi: 10.2147/DDDT.S309964. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 34321867 Free PMC article. Review.
References
-
- Wang, Z., Zhang, X., Wang, H., Qi, L. and Lou, Y., Neuroprotective effects of icaritin against beta amyloid-induced neurotoxicity in primary cultured rat neuronal cells via estrogen-dependent pathway. Neuroscience 2007. 145: 911-922.
-
- Zhang, W., Xing, B., Yang, L., Shi, J. and Zhou, X., Icaritin attenuates myocardial ischemia and reperfusion injury via anti-inflammatory and anti-oxidative stress effects in rats. Am. J. Chin. Med. 2015. 43: 1083-1097.
-
- Qin, L., Yao, D., Zheng, L., Liu, W. C., Liu, Z., Lei, M., Huang, L. et al., Phytomolecule icaritin incorporated PLGA/TCP scaffold for steroid-associated osteonecrosis: proof-of-concept for prevention of hip joint collapse in bipedal emus and mechanistic study in quadrupedal rabbits. Biomaterials 2015. 59: 125-143.
-
- Yao, D., Xie, X. H., Wang, X. L., Wan, C., Lee, Y. W., Chen, S. H., Pei, D. Q. et al., Icaritin, an exogenous phytomolecule, enhances osteogenesis but not angiogenesis-an in vitro efficacy study. PLoS One. 2012. 7: e41264.
-
- Zhou, C., Chen, Z., Lu, X., Wu, H., Yang, Q. and Xu, D., Icaritin activates JNK-dependent mPTP necrosis pathway in colorectal cancer cells. Tumour Biol. 2016. 37: 3135-3144.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials